Well, I stand corrected, they opened at $1.52 and have attracted a 'premium since. That said, they're not exactly worth anything to those who haven't received them under the demerger yet.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025